Nifty

:

23587.50

Sensex

:

78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Login

Nifty
Sensex

:
:

23587.50
78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Cian Healthcare Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 542678 | NSE: Not Listed

Watchlist

NSE BSE

4.34

20-Dec-2024

Open
High
Low
Previous Close

4.35
4.35
4.34
4.42

Volume
Traded Value (lacs)
52 Week High
52 Week Low

36000
1.56
26.50
4.12

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

10.85
42.66
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

65.35
N/A
0.27

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
-

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

-
-
27.91

P:BV (Average)

8 Years
5 Years
3 Years

-
-
0.99

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
12.76

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales - 58.75 67.56 64.10 72.38 57.05 62.44 65.90 51.78 46.68 Net Sales Growth - -13.04% 5.40% -11.44% 26.87% -8.63% -5.25% 27.27% 10.93% Cost Of Goods Sold - 13.74 30.95 28.88 36.05 33.61 40.42 36.01 33.27 32.36 Gross Profit - 45.01 36.61 35.22 36.33 23.44 22.02 29.89 18.51 14.33 GP Margin - 76.61% 54.19% 54.95% 50.19% 41.09% 35.27% 45.36% 35.75% 30.70% Total Expenditure - 51.18 58.50 59.07 62.99 49.41 54.58 52.93 41.69 39.09 Power & Fuel Cost - 0.07 0.07 0.06 0.05 0.09 0.16 0.08 0.09 0.05 % Of Sales - 0.12% 0.10% 0.09% 0.07% 0.16% 0.26% 0.12% 0.17% 0.11% Employee Cost - 7.18 7.76 7.72 6.44 3.96 4.78 3.50 3.64 4.18 % Of Sales - 12.22% 11.49% 12.04% 8.90% 6.94% 7.66% 5.31% 7.03% 8.95% Manufacturing Exp. - 24.45 14.07 14.79 13.30 5.22 4.78 3.78 1.94 0.06 % Of Sales - 41.62% 20.83% 23.07% 18.38% 9.15% 7.66% 5.74% 3.75% 0.13% General & Admin Exp. - 4.16 3.29 3.90 3.43 3.98 3.26 2.82 2.41 2.31 % Of Sales - 7.08% 4.87% 6.08% 4.74% 6.98% 5.22% 4.28% 4.65% 4.95% Selling & Distn. Exp. - 0.62 0.76 0.92 1.14 0.86 0.33 6.73 0.34 0.13 % Of Sales - 1.06% 1.12% 1.44% 1.58% 1.51% 0.53% 10.21% 0.66% 0.28% Miscellaneous Exp. - 0.96 1.61 2.79 2.57 1.71 0.86 0.00 0.00 0.00 % Of Sales - 1.63% 2.38% 4.35% 3.55% 3.00% 1.38% 0% 0% 0% EBITDA - 7.57 9.06 5.03 9.39 7.64 7.86 12.97 10.09 7.59 EBITDA Margin - 12.89% 13.41% 7.85% 12.97% 13.39% 12.59% 19.68% 19.49% 16.26% Other Income - 1.06 0.54 0.47 0.33 0.80 1.02 0.18 0.07 0.47 Interest - 4.93 4.79 5.25 6.40 5.90 5.52 5.94 5.14 3.98 Depreciation - 3.68 3.64 2.57 2.45 2.45 2.39 1.95 1.95 1.93 PBT - 0.01 1.17 -2.31 0.87 0.07 0.98 5.26 3.08 2.16 Tax - -0.38 0.12 -0.10 0.34 0.15 0.29 1.26 0.77 0.61 Tax Rate - -3800.00% 10.00% 4.20% 50.75% 214.29% 30.85% 23.95% 25.00% 28.24% PAT - 0.39 1.08 -2.28 0.33 -0.07 0.66 4.00 2.31 1.55 PAT before Minority Interest - 0.39 1.08 -2.28 0.33 -0.07 0.66 4.00 2.31 1.55 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 0.66% 1.60% -3.56% 0.46% -0.12% 1.06% 6.07% 4.46% 3.32% PAT Growth - -63.89% - - - - -83.50% 73.16% 49.03% EPS - 0.16 0.43 -0.91 0.13 -0.03 0.26 1.60 0.92 0.62

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Net Sales - 61.70 68.59 77.87 73.73 57.09 Net Sales Growth - -10.05% -11.92% 5.62% 29.15% Cost Of Goods Sold - 10.23 18.50 35.59 33.23 33.60 Gross Profit - 51.46 50.09 42.28 40.50 23.49 GP Margin - 83.40% 73.03% 54.30% 54.93% 41.15% Total Expenditure - 51.31 55.60 73.51 61.87 49.81 Power & Fuel Cost - 0.07 0.07 0.06 0.05 0.27 % Of Sales - 0.11% 0.10% 0.08% 0.07% 0.47% Employee Cost - 8.12 8.86 9.37 6.68 4.04 % Of Sales - 13.16% 12.92% 12.03% 9.06% 7.08% Manufacturing Exp. - 26.11 20.86 19.90 14.41 5.23 % Of Sales - 42.32% 30.41% 25.56% 19.54% 9.16% General & Admin Exp. - 4.52 4.94 4.89 3.78 4.10 % Of Sales - 7.33% 7.20% 6.28% 5.13% 7.18% Selling & Distn. Exp. - 1.30 0.76 0.92 1.14 0.86 % Of Sales - 2.11% 1.11% 1.18% 1.55% 1.51% Miscellaneous Exp. - 0.96 1.61 2.79 2.57 1.71 % Of Sales - 1.56% 2.35% 3.58% 3.49% 3.00% EBITDA - 10.39 12.99 4.36 11.86 7.28 EBITDA Margin - 16.84% 18.94% 5.60% 16.09% 12.75% Other Income - 1.12 0.62 0.54 0.40 0.86 Interest - 6.00 6.30 6.55 7.92 7.22 Depreciation - 5.47 5.43 4.27 3.45 4.45 PBT - 0.05 1.88 -5.93 0.90 -3.52 Tax - -0.20 -0.04 -0.47 0.63 0.26 Tax Rate - -400.00% -2.01% 7.83% 91.30% -7.39% PAT - 0.25 2.03 -5.53 0.05 -3.79 PAT before Minority Interest - 0.25 2.03 -5.53 0.05 -3.79 Minority Interest - 0.00 0.00 0.00 0.00 0.00 PAT Margin - 0.41% 2.96% -7.10% 0.07% -6.64% PAT Growth - -87.68% - - - EPS - 0.10 0.81 -2.21 0.02 -1.52

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 61.81 61.42 60.35 59.87 59.55 21.70 17.74 13.29 10.98 Share Capital 25.00 25.00 25.00 23.36 23.36 17.14 1.40 1.40 1.40 Total Reserves 36.82 36.43 35.35 36.51 36.19 4.56 16.34 11.89 9.58 Non-Current Liabilities 24.92 21.22 22.57 21.71 26.46 24.74 25.83 25.54 21.84 Secured Loans 8.63 10.53 17.70 15.30 19.83 17.80 20.49 22.43 14.83 Unsecured Loans 6.66 2.37 2.29 3.08 4.66 5.07 4.11 1.57 5.53 Long Term Provisions 1.02 0.91 0.82 0.75 0.62 0.52 0.00 0.40 0.39 Current Liabilities 56.16 57.99 56.87 53.05 48.57 45.58 33.00 22.45 24.00 Trade Payables 25.14 23.63 28.79 17.71 15.99 15.91 5.23 2.00 10.82 Other Current Liabilities 8.83 12.39 6.62 13.18 5.24 3.48 0.22 4.09 1.75 Short Term Borrowings 21.60 21.44 21.12 21.50 26.94 25.79 25.81 15.68 10.70 Short Term Provisions 0.59 0.54 0.33 0.66 0.40 0.40 1.74 0.67 0.72 Total Liabilities 142.89 140.63 139.79 134.63 134.58 92.02 76.57 61.28 56.82 Net Block 25.88 29.42 32.82 18.73 20.78 23.48 20.00 21.48 18.14 Gross Block 48.41 48.27 48.02 31.37 30.96 31.21 25.39 25.34 20.59 Accumulated Depreciation 22.53 18.85 15.20 12.64 10.18 7.73 5.39 3.86 2.45 Non Current Assets 60.11 62.34 68.09 71.48 61.39 36.55 28.82 32.20 30.13 Capital Work in Progress 14.70 13.89 13.00 25.71 24.80 6.37 6.56 3.69 5.38 Non Current Investment 7.09 7.09 7.09 7.09 7.09 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 12.44 11.95 15.19 19.95 8.72 6.70 2.26 2.49 1.78 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.54 4.82 Current Assets 64.76 68.24 68.79 57.67 73.19 55.47 43.75 29.08 26.69 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 37.68 34.81 34.02 25.71 19.72 15.95 15.83 12.30 12.17 Sundry Debtors 18.30 23.54 18.26 18.54 19.95 22.22 25.57 13.73 12.21 Cash & Bank 0.73 1.13 1.22 2.21 3.02 2.33 0.59 1.07 0.57 Other Current Assets 8.05 0.06 0.16 0.43 30.51 14.97 1.76 1.97 1.75 Short Term Loans & Adv. 8.01 8.71 15.13 10.78 22.54 10.73 1.75 1.93 1.66 Net Current Assets 8.60 10.25 11.92 4.62 24.62 9.89 10.74 6.63 2.69 Total Assets 142.89 140.63 139.78 134.63 134.58 92.02 76.58 61.28 56.82

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Shareholder's Funds 57.74 57.49 55.46 58.24 58.19 Share Capital 25.00 25.00 25.00 23.36 23.36 Total Reserves 32.74 32.49 30.46 34.88 34.83 Non-Current Liabilities 37.32 37.73 41.03 41.22 48.20 Secured Loans 14.43 18.93 27.34 26.61 32.59 Unsecured Loans 13.06 10.45 10.79 11.03 13.24 Long Term Provisions 1.02 0.91 0.82 0.75 0.62 Current Liabilities 66.11 65.27 69.45 57.79 50.03 Trade Payables 31.27 27.10 35.50 20.57 16.93 Other Current Liabilities 12.64 16.00 12.35 14.89 5.25 Short Term Borrowings 21.60 21.44 21.12 21.50 27.32 Short Term Provisions 0.60 0.73 0.48 0.83 0.54 Total Liabilities 161.17 160.49 165.94 157.25 156.42 Net Block 39.28 44.59 49.58 36.54 44.31 Gross Block 70.31 70.14 69.71 52.39 56.71 Accumulated Depreciation 31.03 25.56 20.13 15.85 12.40 Non Current Assets 71.41 76.18 84.08 88.41 79.55 Capital Work in Progress 14.70 13.89 13.00 25.93 25.03 Non Current Investment 4.89 4.89 4.89 4.89 0.00 Long Term Loans & Adv. 12.54 11.82 15.61 20.05 10.21 Other Non Current Assets 0.00 1.00 1.00 1.00 0.00 Current Assets 71.74 74.24 78.96 63.37 76.88 Current Investments 0.00 0.00 0.00 0.00 0.00 Inventories 40.93 36.64 39.37 30.73 19.72 Sundry Debtors 20.48 26.23 26.72 18.90 19.99 Cash & Bank 1.19 1.33 1.34 2.32 4.45 Other Current Assets 9.14 0.07 0.08 0.43 32.72 Short Term Loans & Adv. 9.09 9.97 11.44 10.98 24.75 Net Current Assets 5.63 8.98 9.51 5.58 26.84 Total Assets 161.17 160.47 165.94 157.26 156.43

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 6.94 2.15 5.51 5.46 -9.24 9.21 7.74 6.03 9.89 PBT 0.39 1.08 -2.28 0.33 0.07 0.94 4.00 3.08 2.16 Adjustment 7.82 7.60 7.10 8.10 7.90 7.07 7.64 7.09 5.84 Changes in Working Capital -1.26 -6.53 0.69 -2.96 -17.22 1.21 -3.91 -3.84 2.56 Cash after chg. in Working capital 6.94 2.15 5.51 5.46 -9.24 9.21 7.74 6.34 10.56 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.29 -0.59 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 -0.08 Cash From Investing Activity -0.93 -1.08 -3.85 -1.20 -25.16 -4.69 -2.69 -4.02 -5.08 Net Fixed Assets -0.95 -1.14 -3.94 -1.32 -18.18 -5.63 -2.92 -3.06 Net Investments 0.00 0.00 0.00 0.00 -7.09 0.00 0.00 0.00 Others 0.02 0.06 0.09 0.12 0.11 0.94 0.23 -0.96 Cash from Financing Activity -6.41 -1.17 -2.65 -5.07 35.09 -2.78 -5.53 -1.51 -4.74 Net Cash Inflow / Outflow -0.40 -0.10 -0.99 -0.81 0.69 1.74 -0.48 0.50 0.07 Opening Cash & Equivalents 1.13 1.22 2.21 3.02 2.33 0.59 1.07 0.57 0.50 Closing Cash & Equivalent 0.73 1.13 1.22 2.21 3.02 2.33 0.59 1.07 0.57

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Cash From Operating Activity 11.76 4.84 8.58 5.93 -8.39 PBT 0.25 2.03 -5.53 0.05 -3.52 Adjustment 10.67 10.09 9.67 10.83 10.94 Changes in Working Capital 0.84 -7.28 4.45 -4.95 -15.81 Cash after chg. in Working capital 11.76 4.84 8.58 5.93 -8.39 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1.46 2.55 1.40 2.71 -27.44 Net Fixed Assets -0.95 -1.14 -3.94 -1.32 Net Investments 0.00 0.00 0.00 0.00 Others -0.51 3.69 5.34 4.03 Cash from Financing Activity -10.44 -7.41 -10.96 -9.78 36.87 Net Cash Inflow / Outflow -0.14 -0.01 -0.98 -1.13 1.03 Opening Cash & Equivalents 1.33 1.34 2.32 3.45 3.42 Closing Cash & Equivalent 1.19 1.33 1.34 2.32 4.45

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 17.52 20.55 22.98 23.29 25.49 12.66 980.86 949.61 784.41 ROA 0.27% 0.77% -1.66% 0.24% -0.06% 0.78% 5.81% 3.92% 2.72% ROE 0.82% 1.98% -4.07% 0.62% -0.18% 3.70% 29.64% 19.05% 14.09% ROCE 5.54% 6.16% 2.81% 6.84% 6.59% 9.60% 18.81% 16.77% 14.28% Fixed Asset Turnover 1.28 1.42 1.66 2.38 1.85 2.26 2.65 2.25 2.27 Receivable days 123.48 111.30 102.02 94.72 133.96 136.24 106.73 91.44 95.46 Inventory Days 213.91 183.26 165.60 111.82 113.30 90.60 76.41 86.26 95.16 Payable days 647.60 309.11 293.78 170.55 125.77 72.49 24.04 53.28 99.89 Cash Conversion Cycle -310.22 -14.55 -26.16 35.99 121.49 154.36 159.10 124.41 90.74 Total Debt/Equity 0.94 0.83 0.75 0.91 0.86 2.24 3.67 3.13 2.92 Interest Cover 1.00 1.25 0.55 1.10 1.01 1.17 1.89 1.60 1.54

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Book Value (Rs.) 15.89 18.98 21.03 22.59 24.90 ROA 0.16% 1.24% -3.42% 0.03% -2.42% ROE 0.58% 4.06% -10.51% 0.10% -6.51% ROCE 5.94% 7.41% 0.46% 6.99% 2.81% Fixed Asset Turnover 0.93 1.00 1.33 1.50 1.01 Receivable days 131.14 138.06 102.51 90.63 126.87 Inventory Days 217.76 198.19 157.50 117.56 125.16 Payable days 1041.04 617.44 287.54 202.18 127.26 Cash Conversion Cycle -692.15 -281.19 -27.52 6.01 124.76 Total Debt/Equity 1.40 1.28 1.20 1.33 1.26 Interest Cover 1.01 1.32 0.08 1.09 0.51

Top Investors:

prakashchandra rathi

sonali dilip sanklecha

girija amit sharma

dayal tours and travels india private limited

ravi ashok kothari

sahi trading private limited

kaushal sunil tambe

Annual Reports:

News Update:

No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback